Clinical Trials on Smoldering Plasma Cell Myeloma in Canada
Total 318 results
-
Regeneron PharmaceuticalsRecruiting
-
SanofiActive, not recruitingPlasma Cell MyelomaItaly, Korea, Republic of, Norway, Canada, Spain, Germany, Greece, Lithuania, Sweden, Israel, Hungary, France, Japan, Australia, China, Denmark, Czechia, Turkey, United States, Brazil, Ireland, New Zealand, Poland, United Kingdom
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaCanada
-
AEterna ZentarisCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States, Canada
-
Janssen Research & Development, LLCActive, not recruitingA Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple MyelomaMultiple MyelomaUnited States, Australia, France, United Kingdom, Germany, Israel, Turkey, Netherlands, Canada, Russian Federation, Czechia
-
Janssen Research & Development, LLCActive, not recruitingSmoldering Multiple MyelomaUnited States, Netherlands, Belgium, Canada, Israel, Czechia, Denmark, Japan, Hungary, Turkey, United Kingdom, Spain, Sweden, France, Germany, Italy, Russian Federation, Poland, Mexico, Australia, Brazil, Greece, Argentina, Norway
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada
-
NCIC Clinical Trials GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada
-
AHS Cancer Control AlbertaTom Baker Cancer CentreRecruitingMyeloma | Myeloma MultipleCanada
-
Lawson Health Research InstituteThe Ottawa Hospital; Hamilton Health Sciences Corporation; Dalhousie University; Niagara Health SystemActive, not recruitingMultiple Myeloma in Relapse | Multiple Myeloma With Failed Remission | Multiple Myeloma Stage I | Multiple Myeloma Progression | Multiple Myeloma Stage II | Multiple Myeloma Stage IIICanada
-
SanofiRecruitingPlasma Cell Myeloma RecurrentUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Czechia, France, Germany, Greece, Hungary, Italy, Japan, Norway, Poland, Spain, Sweden, Taiwan, Turkey, United Kingdom
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada, United States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); European Organisation for Research and Treatment... and other collaboratorsCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States, Canada
-
NCIC Clinical Trials GroupCompletedMultiple Myeloma and Plasma Cell NeoplasmCanada, United States
-
SanofiCompletedPlasma Cell MyelomaFrance, Italy, Czechia, Greece, Spain, Canada, Australia, United States, Brazil, Hungary
-
AmgenActive, not recruitingRelapsed or Refractory Multiple Myeloma | Relapsed or Refractory Acute Myeloid LeukemiaUnited States, Australia, Japan, Germany, Canada
-
SanofiActive, not recruitingPlasma Cell MyelomaFrance, United States, Australia, Brazil, Canada, Czechia, Greece, Hungary, Italy, Japan, Korea, Republic of, New Zealand, Russian Federation, Spain, Turkey, United Kingdom
-
AHS Cancer Control AlbertaAbbott; Tom Baker Cancer CentreCompleted
-
SanofiCompletedPlasma Cell MyelomaFrance, Spain, Greece, Korea, Republic of, United States, Australia, Belgium, Canada, Czechia, Denmark, Germany, Hungary, Italy, Japan, New Zealand, Norway, Poland, Portugal, Russian Federation, Slovakia, Sweden, Taiwan, Turkey, United...
-
SanofiRecruitingPlasma Cell MyelomaGermany, United States, Argentina, Austria, Belgium, China, France, Hong Kong, Italy, Japan, Puerto Rico, Russian Federation, Spain, Switzerland, United Arab Emirates, United Kingdom, Kuwait, Saudi Arabia, Netherlands, Taiwan
-
Ottawa Hospital Research InstituteRecruiting
-
University Health Network, TorontoTerminatedLymphoma, Non-Hodgkin | Acute Myeloid Leukemia | Multiple Myeloma | Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | MyelodysplasiaCanada
-
University of ChicagoNational Cancer Institute (NCI)Active, not recruitingStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States, Canada
-
GlaxoSmithKlineTerminatedRelapsed/Refractory Multiple MyelomaAustralia, Sweden, Canada
-
Washington University School of MedicineBristol-Myers Squibb; CelgeneActive, not recruitingMultiple Myeloma in RelapseUnited States, Canada
-
Canadian Cancer Trials GroupCanadian Institutes of Health Research (CIHR); Myeloma CanadaRecruiting
-
K36 Therapeutics, Inc.RecruitingMultiple Myeloma | Myeloma | Myeloma MultipleUnited States, France, Spain, Canada
-
Ciusss de L'Est de l'Île de MontréalExCellThera inc.; Centre C3iActive, not recruitingMultiple MyelomaCanada
-
University of AlbertaCompleted
-
University of AlbertaNot yet recruitingMultiple Myeloma | Exercise | PrehabilitationCanada
-
University Health Network, TorontoMultiple Myeloma Research ConsortiumTerminatedMultiple Myeloma | Relapsed/RefractoryCanada
-
CancerCare ManitobaCompletedLymphoma | Multiple MyelomaCanada
-
NCIC Clinical Trials GroupCompletedPain | Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous/Nonmalignant ConditionCanada
-
London Health Sciences CentreCanadian Institutes of Health Research (CIHR); The Kidney Foundation of CanadaCompletedMultiple Myeloma | Acute Renal FailureCanada
-
ORIC PharmaceuticalsRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Canada
-
TakedaCompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States, Canada
-
Maisonneuve-Rosemont HospitalCompletedMultiple Myeloma | High-Risk CancerCanada
-
Canadian Myeloma Research GroupGlaxoSmithKlineRecruitingRelapsed and/or Refractory Multiple MyelomaCanada
-
Alberta Health Services, CalgaryAlberta Cancer Foundation; University of VictoriaRecruitingLymphoma | Leukemia | Multiple Myeloma | Blood Cancer | Stem Cell Transplant Complications | Chimeric Antigen Receptor T-cell TherapyCanada
-
University of British ColumbiaTerminatedAnti-Xa ActivityCanada
-
Canadian Myeloma Research GroupCompletedMultiple Myeloma in RelapseCanada
-
PETHEMA FoundationBristol-Myers Squibb; Celgene; Adknoma Health Research, S.L.TerminatedMultiple MyelomaSpain
-
Canadian Myeloma Research GroupMerck Sharp & Dohme LLCWithdrawn
-
Dr. Nicole Culos-ReedCompletedHematologic Neoplasms | Multiple Myeloma | Advanced CancerCanada
-
AmgenCompletedRelapsed Multiple MyelomaUnited States, Canada
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Italy, Germany, France, Japan, Israel, Belgium, Denmark, Sweden, Canada, Spain, Czechia, Poland, Australia, Netherlands, United Kingdom, India, China
-
Emory UniversityMillennium Pharmaceuticals, Inc.; Ortho Biotech, Inc.CompletedProtocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple MyelomaMultiple MyelomaUnited States, Canada
-
PETHEMA FoundationRecruitingMultiple Myeloma in RelapseSpain
-
Janssen-Ortho Inc., CanadaOrtho Biotech CanadaNo longer available